Market Overview
The Global Antibody Drug Conjugate (ADC) Technology Market is entering a strong phase of expansion as pharmaceutical companies increasingly focus on targeted cancer therapies that can deliver potent drugs directly to tumor cells. The market is projected to grow from approximately $15.0 billion in 2025 to $36.6 billion by 2035, representing a CAGR of 9.3% during the forecast...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek